NEW YORK, July 31 – Exelixis of South San Francisco, Calif., has appointed Jeffrey Latts chief medical officer and senior vice president for clinical development.

The appointment comes as part of Exelixis plans to step up its drug discovery efforts and advances a newly acquired drug through clinical trials.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.